No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RVMD240621C42000
- 1.19
- -1.66-58.25%
15min DelayClose May 31 15:59 ET
1.67High1.10Low
1.55Open2.85Pre Close44 Volume232 Open Interest42.00Strike Price6.72KTurnover110.58%IV16.10%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry1.19Time Value100Contract SizeAmericanOptions Type0.4112Delta0.0402Gamma15.33Leverage Ratio-0.1019Theta0.0069Rho6.30Eff Leverage0.0341Vega
Intraday
- 5D
- 1D
News
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Revolution Medicines(RVMD.US) Officer Sells US$58,670.87 in Common Stock
$Revolution Medicines(RVMD.US)$ Officer Cislini Jeff sold 1,500 shares of common stock on May 21, 2024 at an average price of $39.1139 for a total value of $58,670.87.Source: Announcement What is stat
Oppenheimer Remains a Buy on Revolution Medicines (RVMD)
Express News | HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $44 Price Target
Buy Rating on Revolution Medicines With a $44 Target Amid Strong Financials and Upcoming Clinical Catalysts
Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...
Comments
» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte(INCY.US$
$BeiGene(BGNE.US$
$ACADIA Pharmaceuticals(ACAD.US$
$Madrigal Pharmaceuticals(MDGL.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Revolution Medicines(RVMD.US$
$Kymera Therapeutics(KYMR.US$
$AbCellera Biologics(ABCL.US$
$Bicycle Therapeutics(BCYC.US$
$Edgewise Therapeutics(EWTX.US$
$Immunocore(IMCR.US$
$Kodiak Sciences(KOD.US$
$Roivant Sciences(ROIV.US$
...
6
$Revolution Medicines(RVMD.US$ rose more than 10% Wednesday after the biotech firm reported the discovery and preclinical-to-clinical translation of its anti-tumor drug RMC-6236.
RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery.
Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...
RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery.
Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...
1
$Revolution Medicines(RVMD.US$
Someone just sold 25000 shares. How good they are in timing.
Someone just sold 25000 shares. How good they are in timing.
Read more